Search results for: 'Manufacturer-to-user demand-oriented services'
- Did you mean
- manufacturer to use demand oriented services
- manufacturer to used demand oriented services
- Related search terms
- Services 2.0: The New Business Frontier for Profitability
- services 20 the new business frontier for profitability
- services market
- services in defense
- services economic implications in automotive industry
-
20 Dec 2022  |  North America  |  Frost Radar
Frost Radar™: Global Medical Imaging Managed Equipment Services Market, 2022
A Benchmarking System to Spark Companies to Action ‒ Innovation That Fuels New Deal Flow and Growth Pipelines
As the number of aging, technologically obsolete imaging systems at medical facilities heightens the need for replacement to new imaging equipment with advanced technology, hospitals and imaging centers (especially in developing economies) seek Managed Equipment Services models that provide a viable long-term equipment procurement strategy. Managed...
$4,950.00
Special Price $3,712.50 save 25 %
-
10 May 2023  |  Global  |  Market Research
Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector
Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential
This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...
$4,950.00
Special Price $3,712.50 save 25 %
-
23 Oct 2020  |  Global  |  Market Research
Supply Chain Optimization and Decentralized Manufacturing to Expand the Contract Cell and Gene Therapy Manufacturing Market, 2020–2026
Automation Deployed to Contain Cost of Goods Sold and Vector Manufacturing Standardization will Create New Growth Opportunities
The cell and gene therapy segment is one of the fastest growing segments in the biopharmaceutical space. While the science behind the therapy has grown by leaps and bounds on the back of decades worth of research, manufacturing has unfortunately lagged behind. To fully harness the curative potential of these therapies and ensure greater reach and a...
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Jul 2023  |  North America  |  Customer Research
Frost & Sullivan Global Cloud User Survey, Q3, 2022
Growing Revenue and Improving Customer Experience Drives Hybrid and Multi-cloud Adoption in Healthcare
Frost & Sullivan’s recent global annual cloud survey’s primary goal is to determine cloud computing technology adoption among healthcare organizations, top business strategic goals, preferred cloud deployment models, information technology (IT), business challenges in cloud migration, and expansion opportunities for healthcare cloud providers. F...
$4,950.00
Special Price $3,712.50 save 25 %
-
31 Jul 2026  |  Global  |  Market Research
Growth Opportunities in Small-Molecule Contract Development and Manufacturing Organizations, Global, 2026–2031
Expansion in Sterile Fill-Finish and ADC-Payload-Linkers Capabilities Will Meet Critical Demand for High-Value Injectables
The global small‑molecule CDMO industry is undergoing a structural transformation driven by increasing molecular complexity, patent expiries, cost pressures, and the strategic need to secure resilient pharmaceutical supply chains. Demand is shifting beyond high‑volume commodity generics toward specialized development and manufacturing capabilities ...
$2,450.00 -
12 Apr 2018  |  Europe  |  Market Research
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth
The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...
$3,000.00
Special Price $2,250.00 save 25 %
-
02 Dec 2025  |  Global  |  Frost Radar
Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC rev...
$4,950.00 -
11 Jul 2023  |  North America  |  Market Research
Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Growth Opportunities
Right Shoring and Targeted Therapeutics Create Future Growth
CDMOs are third-party vendors that offer outsourced development and manufacturing services for pharmaceutical drugs. In the small molecule manufacturing sector, CDMOs provide expert development and manufacturing services and are now an essential part of the pharmaceutical industry's value chain. The growing incidence of chronic diseases propels t...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
10 Sep 2024  |  Global  |  Market Research
Pharmaceutical Commercialization Solutions and Services Industry, Global, 2024 2029
Transformative Precision and Programmatic Marketing Approaches Backed by SaaS-based Service Platforms Drive Pharmaceutical Commercialization
With the growing preference for a patient-centric care delivery approach, the pharma industry follows a robust step-by-step approach towards market commercialization, with a clear understanding of the market stakeholders, segments, as well as post-launch forecasts to create seamless go-to-market strategies. To cater to the ever-evolving market land...
$4,950.00
Special Price $4,207.50 save 15 %